GH Research (STU:1KA) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:1KA GH Research PLC STU:1KA
34 GF Score
Price €25.40
! 2 Warning Signs
View Full Analysis

What is GH Research FFO per Share?

FFO per Share only applies to REITs.

STU:1KA
34GF Score
GH Research PLC STU:1KA
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GH Research Business Description

Other Exchanges GHRS:USA1KA:Germany
Address Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
34GF Score

Get the complete analysis for STU:1KA

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€25.40
Price